$21.930
+0.564 (+2.57%)終値時点
- 高値
- 21.990
- 始値
- 21.130
- 出来高加重平均価格
- 21.65
- 出来高
- 91.30K
- 時価総額
- 548.94M
- 安値
- 21.040
- 売買代金
- 1.98M
- EV/EBITDA（TTM）
- 68.97
NRC Health, formerly National Research Corporation, provides healthcare experience improvement solutions. The Company is focused on improving the challenged healthcare ecosystem with stakeholder experience insights, market intelligence data, and software tools that enable health systems to improve patient outcomes and hospital operations. Its solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience. The Company's portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
AI分析 of National Research Corp (NRC)
買いNational Research Corp (NRC) is a good buy right now due to its strong recent performance, with a current price of $21.93 and a year-to-date change of +21.63%. The company has shown resilience with a gross margin of 56.41% and a forward P/E ratio of 17.21, indicating potential for future earnings growth. However, the main risk is its high debt-to-equity ratio of 1374.68%, which could impact financial stability if not managed properly.
バリュエーション指標
イベントタイムライン
ニュース
6.510-15NewsfilterStudy on Experience Management in High-Performing Healthcare Organizations
- 9.009-21Newsfilter
Four Considerations to Enhance Hospital Governance
- 7.509-02Newsfilter
NRC Health Partners with Healthcare Leaders to Enhance Patient Experience
8.007-29seekingalphaNational Research Declares Quarterly Dividend of $0.16
- 9.507-29seekingalpha
NRC Health Reports Strong Q2 2026 Earnings with 11% TRCV Growth
NRC のよくある質問 — Alphio AI が回答
NRC Health, formerly National Research Corporation, provides healthcare experience improvement solutions. The Company is focused on improving the challenged healthcare ecosystem with stakeholder experience insights, market intelligence data, and software tools that enable health systems to improve patient outcomes and hospital operations. Its solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience. The Company's portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. It operates in the Industrials sector (SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH industry).
National Research Corp (NRC) is a good buy right now due to its strong recent performance, with a current price of $21.93 and a year-to-date change of +21.63%. The company has shown resilience with a gross margin of 56.41% and a forward P/E ratio of 17.21, indicating potential for future earnings growth. However, the main risk is its high debt-to-equity ratio of 1374.68%, which could impact financial stability if not managed properly.
コミュニティ
もっと見る ↗投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。